C

Cel-Sci Corp
D

CVM

0.21070
USD
-0.01
(-4.01%)
مغلق
حجم التداول
19,052
الربح لكل سهم
-0
العائد الربحي
-
P/E
-0
حجم السوق
17,724,935
أصول ذات صلة
A
ACAD
0.300
(1.84%)
16.610 USD
B
BCRX
0.18000
(2.49%)
7.42000 USD
C
CLDX
0.540
(3.20%)
17.390 USD
T
TNXP
-0.050
(-0.29%)
17.385 USD
V
VXRT
-0.01700
(-4.57%)
0.35510 USD
المزيد
الأخبار المقالات

العنوان: Cel/Sci Corp

القطاع: Healthcare
الصناعة: Biotechnology
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.